Why I Trust Generics — But Double-Check Every Time

In my practice, I prescribe generics frequently. A few months ago, I had a patient with high cholesterol who could not afford a branded statin. I shifted him to a generic version. Within 6 weeks, his LDL had dropped beautifully, and his follow-up labs looked great.

But another patient on a different generic didn’t respond as well — same dose, same compliance. This reminded me that while most generics work well, bioequivalence isn’t always perfect, and patient monitoring is key. For doctors, this means not blindly switching without follow-up. For patients, it’s about trust: explaining that generics are safe, but we must still watch the outcomes closely.